Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

Inclusion Criteria

• •Participants are eligible to be included in the study only if ALL of the following criteria are met:
• •Patient with a confirmed diagnosis of VL based on the VL diagnostic algorithm as in the national guidelines, either before treatment or after treatment completion OR healthy individuals with no clinical signs compatible with VL.
• •Participant ≥ 4 years old.
• •Participant from whom written informed consent can be obtained or signed by parent or legal guardian if patient is under 18 years of age. In the case of minors, assent from the children (13-17 years old) will be obtained.
• •Clinical samples required for the study (peripheral blood and urine) can be obtained.